These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 2570627

  • 1. Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy.
    Stoessl AJ, Martin-Iverson MT, Barth TM, Dourish CT, Iversen SD.
    Brain Res; 1989 Aug 21; 495(1):20-30. PubMed ID: 2570627
    [Abstract] [Full Text] [Related]

  • 2. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O.
    Yakubutsu Seishin Kodo; 1988 Dec 21; 8(4):443-51. PubMed ID: 3250156
    [Abstract] [Full Text] [Related]

  • 3. Synergistic behavioural effects of dopamine D1 and D2 receptor agonists are determined by circadian rhythms.
    Martin-Iverson MT, Yamada N.
    Eur J Pharmacol; 1992 Apr 29; 215(1):119-25. PubMed ID: 1355440
    [Abstract] [Full Text] [Related]

  • 4. Behavioural effects induced in rats and chicks by D2 dopamine agonists.
    Ferrari F, Giuliani D.
    Physiol Behav; 1993 Oct 29; 54(4):695-700. PubMed ID: 7902587
    [Abstract] [Full Text] [Related]

  • 5. Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
    Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T.
    Psychopharmacology (Berl); 1990 Oct 29; 100(2):141-4. PubMed ID: 1968276
    [Abstract] [Full Text] [Related]

  • 6. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I, Mizuki Y, Soeda K, Kishimoto O, Hara T, Yamada M.
    Eur J Pharmacol; 1987 Jun 12; 138(1):101-6. PubMed ID: 2887433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L, Cañete T, Guitart-Masip M, Fernández-Teruel A, Tobeña A.
    Physiol Behav; 2005 Nov 15; 86(4):458-66. PubMed ID: 16154604
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.
    Yamada K, Tanaka M, Shibata K, Furukawa T.
    Psychopharmacology (Berl); 1986 Nov 15; 90(1):9-13. PubMed ID: 2945222
    [Abstract] [Full Text] [Related]

  • 13. Modification of apomorphine-induced behaviour following chronic swim exercise in rats.
    Dey S, Singh RH.
    Neuroreport; 1992 Jun 15; 3(6):497-500. PubMed ID: 1391756
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
    Banks RJ, Mozley L, Dourish CT.
    Neuroscience; 1994 Feb 15; 58(4):799-805. PubMed ID: 8190257
    [Abstract] [Full Text] [Related]

  • 16. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I, Tsutsumi C, Hara T, Soeda K, Kishimoto O, Kaneyuki H, Mizuki Y, Yamada M.
    Yakubutsu Seishin Kodo; 1988 Dec 15; 8(4):463-70. PubMed ID: 2907957
    [Abstract] [Full Text] [Related]

  • 17. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
    Abrams DR, Bruno JP.
    Dev Psychobiol; 1992 Nov 15; 25(7):475-95. PubMed ID: 1459343
    [Abstract] [Full Text] [Related]

  • 18. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.
    Fujikawa M, Nagashima M, Inoue T, Yamada K, Furukawa T.
    Pharmacol Biochem Behav; 1996 Apr 15; 53(4):903-9. PubMed ID: 8801596
    [Abstract] [Full Text] [Related]

  • 19. Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.
    Stoessl AJ, Dourish CT, Iversen SD.
    Psychopharmacology (Berl); 1987 Apr 15; 93(3):336-42. PubMed ID: 3124163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.